Our findings with the support of the published data suggested that UCH-L1 might be a potential prognostic biomarker and valuable target in chemoresistance, and its target may improve the chemotherapeutic outcomes in HCC. The gene discussed is UCHL1; the disease is hepatocellular carcinoma.